Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Gundry

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Cell|March 19, 2020
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in MiceMichael C Gundry, Margaret A Goodell, Lorenzo Brunetti
International Journal of Hematology|January 12, 2019
New insights into the biology of acute myeloid leukemia with mutated NPM1Lorenzo Brunetti, Michael C Gundry, Margaret A Goodell
Cold Spring Harbor Perspectives in Medicine|December 23, 2016
DNMT3A in LeukemiaLorenzo Brunetti, Michael C Gundry, Margaret A Goodell
Journal of Visualized Experiments : Jove|May 1, 2018
Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9Lorenzo Brunetti, Michael C Gundry, Ayumi Kitano, et al.
Ejhaem|October 17, 2024
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cellsLorenzo Brunetti, Giulia Pianigiani, Michael C Gundry, et al.
Experimental Hematology|August 1, 2017
Technical considerations for the use of CRISPR/Cas9 in hematology researchMichael C Gundry, Daniel P Dever, David Yudovich, et al.
Genome Biology|September 20, 2017
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3AYung-Hsin Huang, Jianzhong Su, Yong Lei, et al.
Nature Communications|July 12, 2017
Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion proteinYong Lei, Xiaotian Zhang, Jianzhong Su, et al.
Cell Reports|October 27, 2016
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9Michael C Gundry, Lorenzo Brunetti, Angelique Lin, et al.
Blood Advances|September 7, 2021
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilitiesJason H Rogers, Rohit Gupta, Jaime M Reyes, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Cell|March 19, 2020
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in MiceMichael C Gundry, Margaret A Goodell, Lorenzo Brunetti
International Journal of Hematology|January 12, 2019
New insights into the biology of acute myeloid leukemia with mutated NPM1Lorenzo Brunetti, Michael C Gundry, Margaret A Goodell
Cold Spring Harbor Perspectives in Medicine|December 23, 2016
DNMT3A in LeukemiaLorenzo Brunetti, Michael C Gundry, Margaret A Goodell
Journal of Visualized Experiments : Jove|May 1, 2018
Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9Lorenzo Brunetti, Michael C Gundry, Ayumi Kitano, et al.
Ejhaem|October 17, 2024
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cellsLorenzo Brunetti, Giulia Pianigiani, Michael C Gundry, et al.
Experimental Hematology|August 1, 2017
Technical considerations for the use of CRISPR/Cas9 in hematology researchMichael C Gundry, Daniel P Dever, David Yudovich, et al.
Genome Biology|September 20, 2017
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3AYung-Hsin Huang, Jianzhong Su, Yong Lei, et al.
Nature Communications|July 12, 2017
Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion proteinYong Lei, Xiaotian Zhang, Jianzhong Su, et al.
Cell Reports|October 27, 2016
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9Michael C Gundry, Lorenzo Brunetti, Angelique Lin, et al.
Blood Advances|September 7, 2021
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilitiesJason H Rogers, Rohit Gupta, Jaime M Reyes, et al.
Pageof 2